Browsing by Contributors Long, Georgina V

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 12 of 12
PreviewIssue DateTitleContributor(s)
2018 NEJM Volume 378 Issue 19 May (15).pdf.jpg2018Adjuvant Pembrolizumab versus Placebo in Resected Stage III MelanomaMandala, Mario; Long, Georgina V; Ph, D; Atkinson, Victoria; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Rutkowski, Piotr; Schadendorf, Dirk; Ph, D; Koornstra, Rutger; Aya, Leonel Hernandez; Maio, Michele; Ph, D; Marreaud, Sandrine; Akkooi, Alexander C J Van
Lancet 2017 Volume 389 Issue 10083 May (6).pdf.jpg2017Arab youth respond to the Lancet Commission on adolescent health and wellbeingMar, Victoria J; Scolyer, Richard A; Long, Georgina V; Service, Victorian Melanoma; Hospital, Alfred
23.pdf.jpg2-Jul-2015Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaLarkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean Jacques; Cowey, C Lance; Lao, Christopher D; Schadendorf, Dirk; Dummer, Reinhard; Smylie, Michael; Rutkowski, Piotr; Ferrucci, Pier F; Hill, Andrew; Wagstaff, John; Carlino, Matteo S; Haanen, John B; Maio, Michele; Marquez-Rodas, Ivan; McArthur, Grant A; Ascierto, Paolo A; Long, Georgina V; Callahan, Margaret K; Postow, Michael A; Grossmann, Kenneth; Sznol, Mario; Dreno, Brigitte; Bastholt, Lars; Yang, Arvin; Rollin, Linda M; Horak, Christine; Hodi, F Stephen; Wolchok, Jedd D
2017 BJH Volume 177 Issue 1 April (19).pdf.jpg2017Computer-assisted diagnosis for skin cancer: have we been outsmarted?Mar, Victoria J; Scolyer, Richard a; Long, Georgina V
809.pdf.jpgMay-2015Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapyAnforth, Rachael; Menzies, Alexander; Byth, Karen; Carlos, Giuliana; Chou, Shaun; Sharma, Raghwa; Scolyer, Richard A; Kefford, Richard; Long, Georgina V; Fernandez-Peñas, Pablo
30.pdf.jpg1-Jan-2015Improved overall survival in melanoma with combined dabrafenib and trametinibRobert, Caroline; Karaszewska, Boguslawa; Schachter, Jacob; Rutkowski, Piotr; Mackiewicz, Andrzej; Stroiakovski, Daniil; Lichinitser, Michael; Dummer, Reinhard; Grange, Florent; Mortier, Laurent; Chiarion-Sileni, Vanna; Drucis, Kamil; Krajsova, Ivana; Hauschild, Axel; Lorigan, Paul; Wolter, Pascal; Long, Georgina V; Flaherty, Keith; Nathan, Paul; Ribas, Antoni; Martin, Anne-Marie; Sun, Peng; Crist, Wendy; Legos, Jeff; Rubin, Stephen D; Little, Shonda M; Schadendorf, Dirk
2018 JoCO Volume 36 Issue 7 March (1).pdf.jpg2018Long-Term Outcomes in Patients With BRAF V600 – Mutant Metastatic Melanoma Who Received Dabrafenib Combined With TrametinibLong, Georgina V; Eroglu, Zeynep; Infante, Jeffrey; Patel, Sapna; Daud, Adil; Johnson, Douglas B; Gonzalez, Rene; Kefford, Richard; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Sharfman, William; Mcwilliams, Robert; Redhu, Suman; Gasal, Eduard; Mookerjee, Bijoyesh; Web
320.pdf.jpg22-Jan-2015Nivolumab in previously untreated melanoma without BRAF mutationRobert, Caroline; Long, Georgina V; Brady, Benjamin; Dutriaux, Caroline; Maio, Michele; Mortier, Laurent; Hassel, Jessica C; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J; Hernberg, Micaela M; Lebbé, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Arance, Ana; Schmidt, Henrik; Schadendorf, Dirk; Gogas, Helen; Lundgren-Eriksson, Lotta; Horak, Christine; Sharkey, Brian; Waxman, Ian M; Atkinson, Victoria; Ascierto, Paolo A
2016 JCO Volume 34 Issue 8 March (16).pdf.jpg2016Overall Survival and Durable Responses in Patients With BRAF V600 – Mutant Metastatic Melanoma Receiving Dabrafenib Combined With TrametinibLong, Georgina V; Weber, Jeffrey S; Infante, Jeffrey R; Kim, Kevin B; Daud, Adil; Gonzalez, Rene; Sosman, Jeffrey A; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Kefford, Richard F; Lawrence, Donald; Kudchadkar, Ragini; Iii, Howard A Burris; Falchook, Gerald S; Algazi
2017 Lancet Volume 390 Issue 10105 October (1).pdf.jpg2017Pembrolizumab versus ipilimumab for advanced melanoma : final overall survival results of a multicentre , randomised , open-label phase 3 study ( KEYNOTE-006 )Schachter, Jacob; Ribas, Antoni; Long, Georgina V; Arance, Ana; Grob, Jean-jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S; Mcneil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian; Petrella, Teresa M; Hamid, Omid; Zhou, Hongh
2521.pdf.jpg25-Jun-2015Pembrolizumab versus Ipilimumab in Advanced MelanomaRobert, Caroline; Schachter, Jacob; Long, Georgina V; Arance, Ana; Grob, Jean Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S; McNeil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian U; Hamid, Omid; Mateus, Christine; Shapira-Frommer, Ronnie; Kosh, Michele; Zhou, Honghong; Ibrahim, Nageatte; Ebbinghaus, Scot; Ribas, Antoni
JCO 2017 Volume 35 Issue 7 March (13).pdf.jpg2017Safety Pro fi le of Nivolumab Monotherapy : A Pooled Analysis of Patients With Advanced MelanomaWeber, Jeffrey S; Hodi, F Stephen; Wolchok, Jedd D; Topalian, Suzanne L; Schadendorf, Dirk; Larkin, James; Sznol, Mario; Long, Georgina V; Li, Hewei; Waxman, Ian M; Jiang, Joel; Robert, Caroline